INSR and synovial sarcoma: Combination of pazopanib with the IGF1R/InsR dual inhibitor BMS754807 suppressed AKT activation and induced apoptosis in CME-1 cells in agreement with a critical role of the pathway in SS cell growth and survival [23,40].